FDA indicts Snapdeal for selling prescription drugs; Amazon, Flipkart also ‘under’ scanner



By NewsGram Staff Writer

In a major crackdown on the sale of prescription drugs online, The Maharashtra Food & Drugs Administration (FDA) has come down heavily upon e-commerce website Snapdeal.

As per FDA Commissioner Harshadeep Kamble the FDA sleuths raided Snapdeal’s office in Goregaon, north-west Mumbai, after a specific tip-off was received that prescription drugs like Ascoril cough syrup, Viagra tablets, and other medicines were being sold online.

The official said that Snapdeal.com has been asked to provide details of the people involved, medical stores, companies, their respective documents including agreements, challans, invoices, payment details etc.

The FDA directive mandates Snapdeal to immediately withdraw offers for sale and exhibition of such drugs from its e-commerce sites and delist them, which the company has agreed to comply with.

The FDA has also ordered a search of Snapdeal’s offices and godowns in this connection.

Responding to the allegations, Snapdeal denied findings of any such restricted products at their fulfillment centre by the FDA team. Snapdeal, however, assured help to the FDA sleuths in their investigations.

An official spokesperson of Snapdeal said, “Though we periodically educate sellers on engaging in fair and safe sales on the platform and consequences of selling inappropriate products, at times sellers end up listing such products.”

“Upon being notified of any such products, we delist the products and take appropriate action against such seller. In this case, upon receiving the notice, we have delisted the products and provided all information to the FDA team”, he further added.

The FDA Commissioner also said that Flipkart and Amazon offices will also be investigated to ascertain whether they are also indulging in such activities, for which details are being sought.